Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Prospective, Randomized, Active (Warfarin) Controlled, Parallel-arm Clinical Trial to Determine if Participants With an On-X Aortic Valve Can be Maintained Safely and Effectively on Apixaban

NCT04142658 is registered in ClinicalTrials.gov with Artivion Inc. as lead sponsor.

NCT NCT04142658
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04142658 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Prospective, Randomized, Active (Warfarin) Controlled, Parallel-arm Clinical Trial to Determine if Participants With an On-X Aortic Valve Can be Maintained Safely and Effectively on Apixaban
Lead sponsor
Artivion Inc.
Phase
Phase 3
Overall status
Terminated
Start date
May 1, 2020
Completion date
December 12, 2022
Enrollment
863 (actual)
Sites
62

Conditions

As the registry lists them; a condition with its own page is linked.

aortic valve disease, aortic valve failure, aortic valve stenosis